StockTipsArenaBeta

BUY Honasa Consumer — Aastha Jain, Hem Securities

BUYHonasa Consumer
Honasa Consumer share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: NA (inferred Swing (≤2wk))17 Aug 2026via Zee Business (Live)

Entry₹507Inferred
Target₹530
Total upside +4.54% (call closed)
Stop loss₹480-5.33% risk
Exit₹48017 Aug 2026, 3:25 pm
Stop-loss hit-5.33%
Follow Aastha Jain for new calls(32% target hit, 82 closed calls)Get alertsWatch HONASA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Aug 2026
14 supporting3 neutral0 opposing
Supports the BUY call (14)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·17 Aug · today

F&O Talk: Nifty consolidation to continue says Sudeep Shah; gives Tata Motors, Lenskart, Honasa strategy

NewsEt-Markets·15 Aug · 2d ago

(opens in new tab)

Honasa shares hit 52-week high as JM Financial, HDFC Securities turn bullish

NewsHbl·14 Aug · 3d ago

(opens in new tab)

Mamaearth Parent Honasa Shares May Rally 50%, Says ICICI Securities After Strong Q1 Results — Check Hiked Target Price

NewsNdtv-Profit·14 Aug · 3d ago

(opens in new tab)

Honasa Consumer shares jump 4% after record Q1; Jefferies, Emkay forecast strong upside

NewsEt-Markets·14 Aug · 3d ago

(opens in new tab)
Neutral / worth noting (3)

Honasa Consumer Ltd announced the outcome of its Board Meeting held on August 13, 2026. The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 20

BSE · Board Meeting·13 Aug · 3d ago

(opens in new tab)

Honasa Consumer expects no financial impact from Dubai court ruling

NewsGoogle News·8 Aug · 1w ago

(opens in new tab)

Mirae Asset Research Spotlights Honasa, Gland Pharma, Bata, Siemens

NewsGoogle News·4 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Honasa Consumer

All analyst calls on Honasa Consumer

More from Aastha Jain, Hem Securities

Every call and its outcome